Tobias Alexander Selected Research

Tobias Alexander Research Topics

Disease

24	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2008
18	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2009
6	Myasthenia Gravis 01/2022 - 08/2011
5	Multiple Myeloma 02/2020 - 07/2015
4	Multiple Sclerosis 01/2021 - 01/2015
3	Connective Tissue Diseases (Connective Tissue Disease) 05/2022 - 01/2018
3	Inflammation (Inflammations) 01/2021 - 01/2020
3	Crohn Disease (Crohn's Disease) 01/2018 - 12/2017
2	Immunoglobulin G4-Related Disease 05/2022 - 01/2018
2	Autoimmune Diseases of the Nervous System 01/2022 - 02/2020
2	COVID-19 01/2022 - 01/2021
2	Rubella (German Measles) 01/2022 - 01/2022
2	Dermatomyositis (Dermatopolymyositis) 10/2020 - 01/2018
2	Fatigue 10/2020 - 12/2016
2	Rheumatoid Arthritis 01/2019 - 08/2011
2	Systemic Scleroderma (Systemic Sclerosis) 01/2018 - 12/2017
2	Lupus Nephritis 01/2015 - 03/2011
1	Measles 01/2022
1	Mumps 01/2022
1	Polyneuropathies (Polyneuropathy) 01/2022
1	Nemaline Myopathies (Nemaline Myopathy) 01/2022
1	Rheumatic Diseases (Rheumatism) 01/2021
1	Tachycardia (Tachyarrhythmias) 12/2020
1	Takayasu Arteritis (Arteritis, Takayasu's) 11/2020
1	Pain (Aches) 10/2020
1	Polymyositis 10/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 10/2020
1	Inclusion Body Myositis 10/2020
1	Encephalitis (Encephalitis, Rasmussen) 02/2020
1	Sepsis (Septicemia) 02/2020
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2020
1	Cognitive Dysfunction 01/2020
1	Colitis 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Mixed Connective Tissue Disease (MCTD) 01/2018
1	Undifferentiated Connective Tissue Diseases 01/2018
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2017
1	Disease Progression 01/2017
1	Exanthema (Rash) 12/2016
1	Arthritis (Polyarthritis) 12/2016
1	Alopecia (Baldness) 12/2016
1	Nephritis 01/2015
1	Virus Diseases (Viral Diseases) 01/2013
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 08/2011

Drug/Important Bio-Agent (IBA)

6	AutoantibodiesIBA 01/2022 - 03/2015
6	Bortezomib (Velcade)FDA Link 01/2020 - 01/2015
4	Immunoglobulin G (IgG)IBA 01/2022 - 01/2015
4	Proteasome InhibitorsIBA 01/2019 - 07/2015
3	Biomarkers (Surrogate Marker)IBA 05/2022 - 06/2015
3	CytokinesIBA 05/2022 - 11/2014
3	AntigensIBA 01/2022 - 07/2010
3	daratumumabIBA 01/2022 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2022 - 05/2009
2	AntibodiesIBA 01/2022 - 01/2018
2	Complement System Proteins (Complement)IBA 10/2020 - 12/2016
2	Interferon Type IIBA 01/2020 - 01/2013
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2018 - 01/2018
2	anti-dsDNA autoantibodyIBA 12/2016 - 01/2015
1	ChemokinesIBA 05/2022
1	Immunoglobulins (Immunoglobulin)IBA 05/2022
1	COVID-19 VaccinesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2022
1	VaccinesIBA 01/2022
1	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2022
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2021
1	Ligases (Synthetase)IBA 10/2020
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	ATP dependent 26S protease (26S proteasome)IBA 01/2020
1	U1 Small Nuclear RibonucleoproteinIBA 01/2018
1	SteroidsIBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017
1	Rituximab (Mabthera)FDA Link 01/2017
1	belimumabIBA 12/2016
1	Biological ProductsIBA 07/2016
1	Interleukin-2 (IL2)IBA 01/2016
1	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2015
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 06/2015
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 06/2015
1	LigandsIBA 01/2015
1	TACI receptor-IgG Fc fragment fusion proteinIBA 01/2015
1	Antinuclear AntibodiesIBA 11/2014

Therapy/Procedure

12	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2009
12	Therapeutics 01/2022 - 03/2011
10	Stem Cell Transplantation 01/2021 - 01/2008
9	Transplantation 01/2022 - 07/2016
2	Aftercare (After-Treatment) 01/2022 - 01/2020
2	Biological Therapy 01/2021 - 01/2018
1	Immunotherapy 01/2022
1	Catheter Ablation 12/2020
1	Neurological Rehabilitation 02/2020
1	Thymectomy 01/2019
1	Hematopoietic Stem Cell Mobilization 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Treatment Delay 01/2017
1	Plasma Exchange 01/2017